Medical Company Granted Orphan Drug Designation For Lymphoma Treatment

Corvus Pharmaceuticals' Soquelitinib Granted Orphan Drug Designation for T Cell Lymphoma Treatment.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In a significant development for the medical and pharmaceutical industry, Corvus Pharmaceuticals, a pioneering biopharmaceutical company, has announced that its drug, Soquelitinib, has been granted Orphan Drug…